Ziwen Lu
Zhenjiang, 212013, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Expression, molecular mechanisms and therapeutic potentials of ATF1 in cancers.
Journal: Life sciences
Published: September 17, 2024
Investigation of the temporal distribution of anti-VEGF drugs in the retina and the correlation with the distribution of FcR isoforms.
Journal: Genes & diseases
Published: March 27, 2024
PTEN inhibition enhances sensitivity of ovarian cancer cells to the poly (ADP-ribose) polymerase inhibitor by suppressing the MRE11-RAD50-NBN complex.
Journal: British journal of cancer
Published: September 21, 2023
Editorial: Molecular Targets and Therapeutic Strategies in Gynecological Cancers.
Journal: Frontiers in oncology
Published: March 25, 2022
Therapeutic targeting of DNA damage repair pathways guided by homologous recombination deficiency scoring in ovarian cancers.
Journal: Fundamental & clinical pharmacology
Published: March 04, 2022
HSP90 Inhibitor Ganetespib Enhances the Sensitivity of Mantle Cell Lymphoma to Bruton's Tyrosine Kinase Inhibitor Ibrutinib.
Journal: Frontiers in pharmacology
Published: January 28, 2022
RAD54B mutations enhance the sensitivity of ovarian cancer cells to poly(ADP-ribose) polymerase (PARP) inhibitors.
Journal: The Journal of biological chemistry
Published: January 04, 2022
Partitioning defective 6 homolog alpha (PARD6A) promotes epithelial-mesenchymal transition via integrin β1-ILK-SNAIL1 pathway in ovarian cancer.
Journal: Cell death & disease
Published: November 23, 2021
HSP90 inhibition downregulates DNA replication and repair genes via E2F1 repression.
Journal: The Journal of biological chemistry
Published: November 29, 2020
Circular RNAs in hepatocellular carcinoma: Biomarkers, functions and mechanisms.
Journal: Life sciences
Published: May 20, 2019
Last Updated: 09/26/2026